Read more
11:47 AM · 9 October 2024

Bayer drops 7% as Washington court will review another case alleging Monsanto products

-
-
Open account Download free app

Shares of top-German, pharmaceutical and chemical giant, Bayer AG (BAYN.DE) fell today the most since March, as Washington state court will review a case alleging potentially toxic chemicals from the Monsanto, Bayer unit (completed acquisition in 2018). In such case, three teachers claim that, Monsanto product caused brain injuries.

The court denied an application for a 'speedy' review of this case.  According to Bloomberg Intelligence report, Bayer’s exposure to the Roundup litigation (another Monsanto's product) could exceed the Bayer's almosta $16 billion reserve by around 5%. German company has more than 57k unfinished cases related to Roundup; still claiming that Roundup is totally safe. 

Bayer AG (BAYN.DE, D1 interval)

As we can see below, Bayer shares failed to break above resistance of the EMA200 (red line) and now are falling back to levels unseen since half-September.

 

Source: xStation5

13 March 2026, 7:02 PM

Daily summary: Week ends with Brent at 100$ and indices in the red

13 March 2026, 5:21 PM

Amazon: The Beginning of the End of AI Dreams?

13 March 2026, 4:16 PM

BlackRock has a problem, but not a crisis

13 March 2026, 2:32 PM

US OPEN: Cautious gains after GDP disappointment

Join over 2 000 000 XTB Group Clients from around the world
The financial instruments we offer, especially CFDs, can be highly risky. Fractional Shares (FS) is an acquired from XTB fiduciary right to fractional parts of stocks and ETFs. FS are not a separate financial instrument. The limited corporate rights are associated with FS.
This page was not created for investors residing in Brazil. This brokerage is not authorized by the Comissão de Valores Mobiliários (CVM) or the Brazilian Central Bank (BCB). The content of this page should not be characterized as an investment offer in Brazil or for investors residing in that country.
Losses can exceed deposits